Close

Articles Posted in Akers Bioscience

Updated:

Did A Aegis Capital Broker Recommend Biotech Stock Akers Biosciences?

Biotech company Akers Bioscience (AKER) went public in 2014 using Aegis Financial as its investment underwriter. The company’s IPO price was $5 but has subsequently fallen to only $.25.  According to SeekingAlpha not only did Aegis underwrite the security but it also promoted it to investors and potentially the firm’s…

Contact Us